Mann Tobias, Baumhauer Judith F, O'Keefe Regis J, Harrast John, Hurwitz Shepard R, Voloshin Ilya
Department of Orthopaedics and Rehabilitation, University of Rochester, Rochester, NY, USA.
Clin Orthop Relat Res. 2014 Nov;472(11):3510-6. doi: 10.1007/s11999-014-3823-3. Epub 2014 Aug 22.
Primary glenohumeral osteoarthritis is a common indication for shoulder arthroplasty. Historically, both total shoulder arthroplasty (TSA) and hemi-shoulder arthroplasty (HSA) have been used to treat primary glenohumeral osteoarthritis. The choice between procedures is a topic of debate, with HSA proponents arguing that it is less invasive, faster, less expensive, and technically less demanding, with quality of life outcomes equivalent to those of TSA. More recent evidence suggests TSA is superior in terms of pain relief, function, ROM, strength, and patient satisfaction. We therefore investigated the practice of recently graduated orthopaedic surgeons pertaining to the surgical treatment of this disease.
QUESTIONS/PURPOSES: We hypothesized that (1) recently graduated, board eligible, orthopaedic surgeons with fellowship training in shoulder surgery are more likely to perform TSA than surgeons without this training; (2) younger patients are more likely to receive HSA than TSA; (3) patient sex affects the choice of surgery; (4) US geographic region affects practice patterns; and (5) complication rates for HSA and TSA are not different.
We queried the American Board of Orthopaedic Surgery's database to identify practice patterns of orthopaedic surgeons taking their board examination. We identified 771 patients with primary glenohumeral osteoarthritis treated with TSA or HSA from 2006 to 2011. The rates of TSA and HSA were compared based on the treating surgeon's fellowship training, patient age and sex, US geographic region, and reported surgical complications.
Surgeons with fellowship training in shoulder surgery were more likely (86% versus 72%; OR 2.32; 95% CI, 1.56-3.45, p<0.001) than surgeons without this training to perform TSA rather than HSA. The mean age for patients receiving HSA was not different from that for patients receiving TSA (66 versus 68, years, p=0.057). Men were more likely to receive HSA than TSA when compared to women (RR 1.54; 95% CI, 1.19-2.00, p=0.0012). The proportions of TSA and HSA were similar regardless of US geographic region (Midwest HSA 21%, TSA 79%; Northeast HSA 25%, TSA 75%; Northwest HSA 16%, TSA 84%; South HSA 27%, TSA 73%; Southeast HSA 24%, TSA 76%; Southwest HSA 23%, TSA 77%; overall p=0.708). The overall complication rates were not different with the numbers available: 8.4% (15/179) for HSA and 8.1% (48/592) for TSA (p=0.7555).
The findings of this study are at odds with the recommendations in the current clinical practice guidelines for the treatment of glenohumeral osteoarthritis published by the American Academy of Orthopaedic Surgeons. These guidelines favor using TSA over HSA in the treatment of shoulder arthritis. Further investigation is needed to clarify if these practice patterns are isolated to recently graduated board eligible orthopaedic surgeons or if the use of HSA continues with orthopaedic surgeons applying for recertification.
Level III, therapeutic study. See Instructions for Authors for a complete description of levels of evidence.
原发性盂肱关节骨关节炎是肩关节置换术的常见适应证。从历史上看,全肩关节置换术(TSA)和半肩关节置换术(HSA)都曾用于治疗原发性盂肱关节骨关节炎。两种手术方式的选择一直是个有争议的话题,HSA的支持者认为它创伤小、速度快、费用低且技术要求低,生活质量结果与TSA相当。最近的证据表明,TSA在缓解疼痛、功能、活动范围、力量和患者满意度方面更具优势。因此,我们调查了刚毕业的骨科医生对这种疾病的手术治疗方法。
问题/目的:我们假设:(1)最近毕业、符合委员会资格且接受过肩部手术专科培训的骨科医生比未接受此培训的医生更倾向于进行TSA;(2)年轻患者比TSA患者更有可能接受HSA;(3)患者性别会影响手术选择;(4)美国地理区域会影响手术方式;(5)HSA和TSA的并发症发生率没有差异。
我们查询了美国骨科医师委员会的数据库,以确定参加委员会考试的骨科医生的手术方式。我们确定了2006年至2011年期间接受TSA或HSA治疗的771例原发性盂肱关节骨关节炎患者。根据治疗医生的专科培训、患者年龄和性别、美国地理区域以及报告的手术并发症,比较TSA和HSA的比例。
接受过肩部手术专科培训的医生比未接受此培训的医生更倾向于进行TSA而非HSA(86%对72%;OR 2.32;95%CI,1.56 - 3.45,p<0.001)。接受HSA的患者的平均年龄与接受TSA的患者的平均年龄没有差异(66岁对68岁,p = 0.057)。与女性相比,男性接受HSA的可能性高于TSA(RR 1.54;95%CI,1.19 - 2.00,p = 0.0012)。无论美国地理区域如何,TSA和HSA的比例相似(中西部地区HSA 21%,TSA 79%;东北地区HSA 25%,TSA 75%;西北地区HSA 16%,TSA 84%;南部地区HSA 27%,TSA 73%;东南部地区HSA 24%,TSA 76%;西南部地区HSA 23%,TSA 77%;总体p = 0.708)。现有数据显示总体并发症发生率没有差异:HSA为8.4%(15/179),TSA为8.1%(48/592)(p = 0.7555)。
本研究的结果与美国骨科医师学会发布的当前盂肱关节骨关节炎治疗临床实践指南中的建议不一致。这些指南在治疗肩部关节炎时更倾向于使用TSA而非HSA。需要进一步调查以明确这些手术方式是否仅限于最近毕业且符合委员会资格的骨科医生,或者申请重新认证的骨科医生是否仍会继续使用HSA。
III级,治疗性研究。有关证据级别的完整描述,请参阅作者指南。